Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
The proteasome regulates cellular processes as diverse as cell cycle progression and NF-κB activation. In this study, we show that the potent antitumor natural product epoxomicin specifically targets the proteasome. Utilizing biotinylated-epoxomicin as a molecular probe, we demonstrate that epoxomicin covalently binds to the LMP7, X, MECL1, and Z catalytic subunits of the proteasome. Enzymatic analyses with purified bovine erythrocyte proteasome reveal that epoxomicin potently inhibits primarily the chymotrypsin-like activity. The trypsin-like and peptidyl-glutamyl peptide hydrolyzing catalytic activities also are inhibited at 100- and 1,000-fold slower rates, respectively. In contrast to peptide aldehyde proteasome inhibitors, epoxomicin does not inhibit nonproteasomal proteases such trypsin, chymotrypsin, papain, calpain, and cathepsin B at concentrations of up to 50 μM. In addition, epoxomicin is a more potent inhibitor of the chymotrypsin-like activity than lactacystin and the peptide vinyl sulfone NLVS. Epoxomicin also effectively inhibits NF-κB activation in vitro and potently blocks in vivo inflammation in the murine ear edema assay. These results thus define epoxomicin as a novel proteasome inhibitor that likely will prove useful in exploring the role of the proteasome in various in vivo and in vitro systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,487
Structure of 20S proteasome from yeast at 2.4Å resolution
Groll, M., Ditzel, L., Löwe, J., Stock, D., Bochtler, M., Bartunik, H. D., & Huber, R. (1997) · Nature · doi:10.1038/386463a0 · Cited by 2,257
Palombella, V. J., Rando, O. J., Goldberg, A. L., & Maniatis, T. (1994) · Cell · doi:10.1016/s0092-8674(94)90482-0 · Cited by 2,096
Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583
Proteasome inhibitors: valuable new tools for cell biologists.
Lee, D. H., & Goldberg, A. L. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01346-4 · Cited by 1,474
The ubiquitin-proteasome pathway: on protein death and cell life
Ciechanover, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7151 · Cited by 1,426
Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain
Treier, M., Staszewski, L. M., & Bohmann, D. (1994) · Cell · doi:10.1016/s0092-8674(94)90502-9 · Cited by 923
Traenckner, E. B., Wilk, S., & Baeuerle, P. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06878.x · Cited by 710
Varshavsky, A. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01122-5 · Cited by 545
MHC-linked LMP gene products specifically alter peptidase activities of the proteasome
Driscoll, J., Brown, M. G., Finley, D., & Monaco, J. J. (1993) · Nature · doi:10.1038/365262a0 · Cited by 448
Bogyo, M., McMaster, J. S., Gaczynska, M., Tortorella, D., Goldberg, A. L., & Ploegh, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6629 · Cited by 447
Craiu, A., Gaczynska, M., Akopian, T., Gramm, C. F., Fenteany, G., Goldberg, A. L., & Rock, K. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13437 · Cited by 382
A Giant Protease with Potential to Substitute for Some Functions of the Proteasome
Geier, E., Pfeifer, G., Wilm, M., Lucchiari-Hartz, M., Baumeister, W., Eichmann, K., & Niedermann, G. (1999) · Science · doi:10.1126/science.283.5404.978 · Cited by 375
Proteasomes: destruction as a programme
Hilt, W., & Wolf, D. H. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10012-8 · Cited by 368
Read, M. A., Neish, A. S., Luscinskas, F. W., Palombella, V. J., Maniatis, T., & Collins, T. (1995) · Immunity · doi:10.1016/1074-7613(95)90030-6 · Cited by 347
Piguet, P. F., Grau, G. E., Hauser, C., & Vassalli, P. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.673 · Cited by 340
Orlowski, M., Cardozo, C., & Michaud, C. (1993) · Biochemistry · doi:10.1021/bi00057a022 · Cited by 321
Boes, B., Hengel, H., Ruppert, T., Multhaup, G., Koszinowski, U. H., & Kloetzel, P. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.901 · Cited by 319
Role of the proteasome and NF-κB in streptococcal cell wall-induced polyarthritis
Palombella, V. J., Conner, E. M., Fuseler, J. W., Destree, A., Davis, J. M., Laroux, F. S., Wolf, R. E., Huang, J., Brand, S., Elliott, P. J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15671 · Cited by 287
Heinemeyer, W., Gruhler, A., Möhrle, V., Mahé, Y., & Wolf, D. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53509-2 · Cited by 258
Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex
Vinitsky, A., Michaud, C., Powers, J. C., & Orlowski, M. (1992) · Biochemistry · doi:10.1021/bi00154a014 · Cited by 217
The ubiquitin-proteasome pathway in cancer
Spataro, V, Norbury, C., & Harris, A. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.71 · Cited by 215
Epoxomicin, a new antitumor agent of microbial origin.
HANADA, M., SUGAWARA, K., KANETA, K., TODA, S., NISHIYAMA, Y., TOMITA, K., YAMAMOTO, H., KONISHI, M., & OKI, T. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.1746 · Cited by 213
Sin, N., Kim, K. B., Elofsson, M., Meng, L., Auth, H., Kwok, B. H. B., & Crews, C. M. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00376-5 · Cited by 207
Self-citationBogyo, M., Shin, S., McMaster, J. S., & Ploegh, H. L. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90169-7 · Cited by 178
Eponemycin exerts its antitumor effect through the inhibition of proteasome function.
Meng, L., Kwok, B. H. B., Sin, N., & Crews, C. M. (1999) · PubMed · Cited by 172
Self-citationGrabbe, S., Steinert, M., Mahnke, K., Schwartz, A., Luger, T. A., & Schwarz, T. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118899 · Cited by 156
Brömme, D., Klaus, J. L., Okamoto, K., Rasnick, D., & Palmer, J. T. (1996) · Biochemical Journal · doi:10.1042/bj3150085 · Cited by 141
Coutts, S. J., Kelly, T. A., Snow, R. J., Kennedy, C. A., Barton, R. W., Adams, J., Krolikowski, D. A., Freeman, D. M., Campbell, S. J., Ksiazek, J., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950732f · Cited by 133
The ubiquitin-mediated proteolytic pathway as a therapeutic area
Rolfe, M., Chiu, M. I., & Pagano, M. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050081 · Cited by 122
Ostrowska, H., Wójcik, C., Ōmura, S., & Worowski, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6434 · Cited by 122
Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities.
Loveren, H. V., & Askenase, P. W. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.5.2397 · Cited by 110
Sugawara, K., Hatori, M., Nishiyama, Y., et al. (1990) · The Journal of Antibiotics · doi:10.7164/antibiotics.43.8 · Cited by 100
Mohan, R., Rinehart, W. B., Bargagna-Mohan, P., & Fini, M. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25903 · Cited by 99
Self-citationActive Site-directed Inhibitors of Rhodococcus 20 S Proteasome
Mc Cormack, T., Baumeister, W., Grenier, L., Moomaw, C., Plamondon, L., Pramanik, B., Slaughter, C., Soucy, F., Stein, R., Zühl, F., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26103 · Cited by 62
Mellgren, R. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29899 · Cited by 57
Spaltenstein, A., Leban, J. J., Huang, J. J., Reinhardt, K. R., Viveros, O. H., Sigafoos, J., & Crouch, R. C. (1996) · Tetrahedron Letters · doi:10.1016/0040-4039(96)00018-4 · Cited by 49
Cited by
Sakamoto, K. M., Kim, K. B., Kumagai, A., Mercurio, F., Crews, C. M., & Deshaies, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141230798 · Cited by 2,609
Self-citationCatalytic in vivo protein knockdown by small-molecule PROTACs
Bondeson, D. P., Mares, A., Smith, I. E. D., Ko, E., Campos, S., Miah, A. H., Mulholland, K. E., Routly, N., Buckley, D. L., Gustafson, J. L., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1858 · Cited by 1,356
Self-citationImpact of Natural Products on Developing New Anti-Cancer Agents
Cragg, G. M., Grothaus, P. G., & Newman, D. J. (2009) · Chemical Reviews · doi:10.1021/cr900019j · Cited by 1,302
Proteasome inhibitors: from research tools to drug candidates
Kisselev, A. F., & Goldberg, A. L. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00056-4 · Cited by 1,184
Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy
Ravikumar, B. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.9.1107 · Cited by 1,111
Metadata
- Authors
- Meng, L., Mohan, R., Kwok, B. H. B., Elofsson, M., Sin, N., & Crews, C. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-08-31
- Volume
- 96
- Issue
- 18
- Pages
- 10403-10408
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2159831275
- Cited by
- 920
- References
- 39
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.